Research Agenda in Childhood Impairing Emotional Outbursts: A Report of the AACAP Presidential Taskforce on Emotional Dysregulation. JAACAP Open. 2025; 3(1):147-155.
Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55(6):1969-1975.
Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55(3):940-954.
ZMYND11 functions in bimodal regulation of latent genes and brain-like splicing to safeguard corticogenesis. Nature Communications. 2025; 16(1):9010.
FX ENTRAIN: scientific context, study design, and biomarker driven brain-computer interfaces in neurodevelopmental conditions. Frontiers in Neuroscience. 2025; 19:1618804.
Examining Alternative Treatment Settings for Adolescents With Suicidal Thoughts During the COVID-19 Pandemic. JAACAP Open. 2025; 3(3):567-575.
Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trial. The Lancet Psychiatry. 2025; 12(12):893-905.
53.4 Metformin for Overweight and Obese Children With Bipolar Spectrum Disorders Treated With Second-Generation Antipsychotics: 24-Month Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64(10):s413-s414.
Dual Diagnosis of Fragile X Syndrome and DEPDC5-Related Disorder Emphasizes DEPDC5's Role Beyond Familial Epilepsy: A Case Report and Literature Review. Case Reports in Genetics. 2025; 2025:4501466.
Editorial: Physical Activity and Depression in Youth: Insights From a Longitudinal Birth Cohort Study. Journal of the American Academy of Child and Adolescent Psychiatry. 2025.
Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome. Molecular Autism. 2025; 16(1):49.
Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2025; 35(4):231-243.
Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55(9):3387-3394.
Safety and Effectiveness of Clozapine in Youth and Young Adults with Neurodevelopmental Disorders and Severe, Treatment-Refractory Irritability and Aggression: A Retrospective Chart Review. Journal of Child and Adolescent Psychopharmacology. 2025; 35(6):337-346.
Alpha-2 Agonists in Autism Spectrum Disorder. In: Lifespan Treatment for Autistic Individuals. Oxford University Press (OUP); 2025:607-620.
Metabolic syndrome in youth with bipolar spectrum disorders treated with second-generation antipsychotics: baseline results from the community-based pragmatic MOBILITY Trial. European Child and Adolescent Psychiatry. 2025; 34(9):2917-2929.
Relationship Between Intellectual Disability and Behavioral Comorbidity in Children With Fragile X Syndrome. Journal of Autism and Developmental Disorders. 2025.
Cytochrome P450 2D6 *17 and *29 Allele Activity for Risperidone Metabolism: Advancing Precision Medicine Health Equity. Clinical Pharmacology and Therapeutics. 2025; 118(5):1152-1160.
Juggler's ASR: Unpacking the principles of artifact subspace reconstruction for revision toward extreme MoBI. Journal of Neuroscience Methods. 2025; 420:110465.
Emerging role of complement system in the induction of neuroinflammation in adenylosuccinate lyase deficiency disorder. Brain, Behavior, & Immunity - Health. 2025; 48:101091.
The Influence of Project ECHO and Integrated Behavioral Health in Primary Care on Emergency Department Visits Among Youth Diagnosed with Depression. Journal of Behavioral Health Services and Research. 2025; 52(2):357-366.
Brief Report: Differences Between Stanford-Binet Abbreviated and Full-Scale Estimates of IQ in Fragile X Syndrome Vary Across Development. Journal of Autism and Developmental Disorders. 2025.
Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2025; 35(4):211-221.
Beyond the Fragile X protein: neighborhood characteristics explain individual differences in IQ and adaptive behaviors of Fragile X syndrome. Frontiers in Psychiatry. 2025; 16:1636987.
EEG power modulation in the sensorimotor regions is critical to motor tic suppression. Frontiers in Psychiatry. 2025; 16:1580636.
Hyper-extralemniscal model of Fragile X syndrome. Cerebral Cortex. 2025; 35(6).
Health Related Quality of Life in Autistic Youth and Their Families. Journal of Autism and Developmental Disorders. 2025; 55(6):1982-1987.
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity. Journal of Child and Adolescent Psychopharmacology. 2025; 35(7):399-415.
Cognitive Flexibility in Autism: New Tools for Understanding and Treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64(10):s335.
Frontal cortex hyperactivation and gamma desynchrony in Fragile X syndrome: Correlates of auditory hypersensitivity. PLoS ONE. 2025; 20(5):e0306157.
Systematic Search and Review: Management and Prevention of Agitation and Aggression in the Child and Adolescent Psychiatric Inpatient Setting. Journal of Child and Adolescent Psychopharmacology. 2025; 35(7):375-387.
Conferring a Genetic Diagnosis for Children with Neurodevelopmental Disorders in the Inpatient Psychiatry Setting May Reduce Hospital Stays and Improve Behavior. Advances in Neurodevelopmental Disorders. 2025; 1-15.
Raising the Bar: Growth of Specialized Hospital Psychiatric Units for Youths With Neurodevelopmental Disabilities. Psychiatric Services. 2025; 76(12):1050-1056.
Is Pediatric Catatonia on the Rise? Hospital pediatrics. 2025; 15(9):e449-e452.
Screening tool for predicting patient aggressive behavior and staff injury at a pediatric hospital. Journal of Psychiatric Research. 2025; 186:373-378.
Psychopharmacology in Autism. In: Handbook of Evidence-Based Practices in Autism Spectrum Disorder. Springer Nature; 2025:315-340.
Psychopharmacology in Autism. In: Handbook of Evidence Based Practices in Autism Spectrum Disorder. 2025:315-340.